Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Intra-abdominal Infections Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Intra-abdominal infections resulting in gastrointestinal emergencies
5.1.1.2. Rapidly growing pharmaceutical industry, and rise in demand for cost-effective and efficient treatment
5.1.1.3. Rowing resistance to antimicrobials such as penicillin and related beta-lactam antibiotics
5.1.2. Restraints
5.1.2.1. Penetration of generics resulting in pricing pressure
5.1.3. Opportunities
5.1.3.1. Discover of new drugs for the treatment of intra-abdominal infections by pharmaceutical companies
5.1.3.2. Increase in public–private partnerships to promote research at academic levels, and awareness about antibiotic therapy
5.1.4. Challenges
5.1.4.1. Excessive production capacity of antimicrobials
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Intra-abdominal Infections Market, by Diagnosis
6.1. Introduction
6.2. Abdominal X-ray
6.3. Blood Tests
6.4. Computed Tomography (CT)
6.5. Ultrasound

7. Intra-abdominal Infections Market, by Drugs
7.1. Introduction
7.2. Ceftriaxone
7.3. Chloramphenicol
7.4. Clindamycin
7.5. Metronidazole

8. Americas Intra-abdominal Infections Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Intra-abdominal Infections Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Intra-abdominal Infections Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AstraZeneca PLC
12.1.2. Boehringer Ingelheim GmbH
12.1.3. Bristol-Myers Squibb Company
12.1.4. Cipla Ltd.
12.1.5. Dr Reddy’s Laboratories Ltd.
12.1.6. Eli Lilly and Company
12.1.7. GlaxoSmithKline PLC
12.1.8. Merck KGaA
12.1.9. Mylan Pharmaceuticals Inc.
12.1.10. Pfizer Inc.
12.1.11. Sanofi SA
12.1.12. Smith & Nephew PLC
12.1.13. Sun Pharmaceutical Industries, Inc.
12.1.14. Teva Pharmaceutical Industries Ltd.
12.1.15. Thermo Fisher Scientific Inc.
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. INTRA-ABDOMINAL INFECTIONS MARKET RESEARCH PROCESS
FIGURE 2. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, 2023 VS 2030
FIGURE 3. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. INTRA-ABDOMINAL INFECTIONS MARKET DYNAMICS
FIGURE 7. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2023 VS 2030 (%)
FIGURE 8. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2023 VS 2030 (%)
FIGURE 10. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. INTRA-ABDOMINAL INFECTIONS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. INTRA-ABDOMINAL INFECTIONS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. INTRA-ABDOMINAL INFECTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 6. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY ABDOMINAL X-RAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT), BY REGION, 2018-2030 (USD MILLION)
TABLE 9. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 11. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY CEFTRIAXONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY CHLORAMPHENICOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY CLINDAMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY METRONIDAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 22. CANADA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 23. CANADA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 24. MEXICO INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 25. MEXICO INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 31. ASIA-PACIFIC INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 33. AUSTRALIA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 34. CHINA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 35. CHINA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 36. INDIA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 37. INDIA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 39. INDONESIA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 40. JAPAN INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 41. JAPAN INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 43. MALAYSIA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 45. PHILIPPINES INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 47. SINGAPORE INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 49. SOUTH KOREA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 51. TAIWAN INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 52. THAILAND INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 53. THAILAND INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 55. VIETNAM INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. DENMARK INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 60. DENMARK INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 61. EGYPT INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 62. EGYPT INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 63. FINLAND INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 64. FINLAND INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 65. FRANCE INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 66. FRANCE INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 67. GERMANY INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 68. GERMANY INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 70. ISRAEL INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 71. ITALY INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 72. ITALY INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 74. NETHERLANDS INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 76. NIGERIA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 77. NORWAY INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 78. NORWAY INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 79. POLAND INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 80. POLAND INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 81. QATAR INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 82. QATAR INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 86. SAUDI ARABIA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 88. SOUTH AFRICA INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 89. SPAIN INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 90. SPAIN INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 92. SWEDEN INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 94. SWITZERLAND INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 95. TURKEY INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 96. TURKEY INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM INTRA-ABDOMINAL INFECTIONS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 101. INTRA-ABDOMINAL INFECTIONS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 102. INTRA-ABDOMINAL INFECTIONS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 103. INTRA-ABDOMINAL INFECTIONS MARKET LICENSE & PRICING